SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    J. Naqvi, E. Nagaraju, S. Ahmad, MRI appearances of pure epithelial papillary serous borderline ovarian tumours, Clinical Radiology, 2015, 70, 4, 424

    CrossRef

  2. 2
    Limor Helpman, Mario E. Beiner, Sarit Aviel-Ronen, Tamar Perri, Liat Hogen, Ariella Jakobson-Setton, Gilad Ben-Baruch, Jacob Korach, Safety of ovarian conservation and fertility preservation in advanced borderline ovarian tumors, Fertility and Sterility, 2015, 104, 1, 138

    CrossRef

  3. 3
    Charlotte Gerd Hannibal, Russell Vang, Jette Junge, Kirsten Frederiksen, Anette Kjaerbye-Thygesen, Klaus Kaae Andersen, Ann Tabor, Robert J. Kurman, Susanne K. Kjaer, A nationwide study of serous “borderline” ovarian tumors in Denmark 1978–2002: Centralized pathology review and overall survival compared with the general population, Gynecologic Oncology, 2014, 134, 2, 267

    CrossRef

  4. 4
    F. Trillsch, S. Mahner, L. Woelber, E. Vettorazzi, A. Reuss, N. Ewald-Riegler, N. de Gregorio, C. Fotopoulou, B. Schmalfeldt, A. Burges, F. Hilpert, T. Fehm, W. Meier, P. Hillemanns, L. Hanker, A. Hasenburg, H. G. Strauss, M. Hellriegel, P. Wimberger, K. Baumann, M. D. Keyver-Paik, U. Canzler, K. Wollschlaeger, D. Forner, J. Pfisterer, W. Schroeder, K. Muenstedt, B. Richter, F. Kommoss, S. Hauptmann, A. du Bois, Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study, Annals of Oncology, 2014, 25, 7, 1320

    CrossRef

  5. 5
    Vera Loizzi, Luigi Selvaggi, Luca Leone, Donatella Latorre, Doriana Scardigno, Francescapaola Magazzino, Gennaro Cormio, Borderline epithelial tumors of the ovary: Experience of 55 patients, Oncology Letters, 2014,

    CrossRef

  6. 6
    L.-C. Horn, J. Einenkel, R. Handzel, A.K. Höhn, Morphologie sekundärer Ovarialtumoren/Ovarmetastasen, Der Pathologe, 2014, 35, 4, 336

    CrossRef

  7. 7
    Elena Braicu, Toon Van Gorp, Mani Nassir, Rolf Richter, Radoslav Chekerov, Khayal Gasimli, Dirk Timmerman, Ignace Vergote, Jalid Sehouli, Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) – a study of the TOC Consortium, Journal of Ovarian Research, 2014, 7, 1, 49

    CrossRef

  8. 8
    Taejong Song, Yoo-Young Lee, Chel Hun Choi, Tae-Joong Kim, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim, Risk Factors for Progression to Invasive Carcinoma in Patients With Borderline Ovarian Tumors, International Journal of Gynecological Cancer, 2014, 24, 7, 1206

    CrossRef

  9. 9
    Gynaecologic Cancer, 2014,

    CrossRef

  10. 10
    Cyllene R. Morris, Lihua Liu, Anne O. Rodriguez, Rosemary D. Cress, Kurt Snipes, Epidemiologic features of borderline ovarian tumors in California: a population-based study, Cancer Causes & Control, 2013, 24, 4, 665

    CrossRef

  11. 11
    Susanne Schüler, Marvin Ponnath, Jörg Engel, Olaf Ortmann, Ovarian epithelial tumors and reproductive factors: a systematic review, Archives of Gynecology and Obstetrics, 2013, 287, 6, 1187

    CrossRef

  12. 12
    Fabian Trillsch, Jan Ruetzel, Uwe Herwig, Ulrike Doerste, Linn Woelber, Donata Grimm, Matthias Choschzick, Fritz Jaenicke, Sven Mahner, Surgical management and perioperative morbidity of patients with primary borderline ovarian tumor (BOT), Journal of Ovarian Research, 2013, 6, 1, 48

    CrossRef

  13. 13
    Claes Göran Tropé, Janne Kaern, Ben Davidson, Borderline ovarian tumours, Best Practice & Research Clinical Obstetrics & Gynaecology, 2012, 26, 3, 325

    CrossRef

  14. 14
    Nina Ewald-Riegler, Oya du Bois, Annette Fisseler-Eckhoff, Friedrich Kommoss, Philipp Harter, Alexander Traut, Rita Hils, Andreas du Bois, Borderline Tumors of the Ovary: Clinical Course and Prognostic Factors, Onkologie, 2012, 35, 1-2, 28

    CrossRef

  15. 15
    Brigitte L. Thériault, Sanja Pajovic, Marcus Q. Bernardini, Patricia A. Shaw, Brenda L. Gallie, Kinesin family member 14: An independent prognostic marker and potential therapeutic target for ovarian cancer, International Journal of Cancer, 2012, 130, 8
  16. 16
    Willi Oberaigner, Pamela Minicozzi, Magdalena Bielska-Lasota, Claudia Allemani, Roberta de Angelis, Lucia Mangone, Milena Sant, Survival for Ovarian Cancer in Europe: The across-country variation did not shrink in the past decade, Acta Oncologica, 2012, 51, 4, 441

    CrossRef

  17. 17
    Mine Kanat-Pektas, Mustafa Ozat, Tayfun Gungor, Izzet Sahin, Hakan Yalcin, Bulent Ozdal, Complete lymph node dissection: is it essential for the treatment of borderline epithelial ovarian tumors?, Archives of Gynecology and Obstetrics, 2011, 283, 4, 879

    CrossRef

  18. 18
    Mine Kanat-Pektas, Mustafa Ozat, Tayfun Gungor, Türkan Dikici, Bulent Yilmaz, Leyla Mollamahmutoglu, Fertility outcome after conservative surgery for borderline ovarian tumors: a single center experience, Archives of Gynecology and Obstetrics, 2011, 284, 5, 1253

    CrossRef

  19. 19
    Guro Aune, Aina-Mari Lian, Solveig Tingulstad, Sverre H. Torp, Siri Forsmo, Janne Elin Reseland, Astrid Kamilla Stunes, Unni Syversen, Increased circulating hepatocyte growth factor (HGF): A marker of epithelial ovarian cancer and an indicator of poor prognosis, Gynecologic Oncology, 2011, 121, 2, 402

    CrossRef

  20. 20
    Linda E Kelemen, Martin Köbel, Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma, The Lancet Oncology, 2011, 12, 11, 1071

    CrossRef

  21. 21
    Mark A. Rettenmaier, Katrina Lopez, Lisa N. Abaid, John V. Brown, John P. Micha, Bram H. Goldstein, Borderline ovarian tumors and extended patient follow-up: An individual institution's experience, Journal of Surgical Oncology, 2010, 101, 1
  22. 22
    F Trillsch, S Mahner, JD Ruetzel, P Harter, N Ewald-Riegler, F Jaenicke, A du Bois, Clinical management of borderline ovarian tumors, Expert Review of Anticancer Therapy, 2010, 10, 7, 1115

    CrossRef

  23. 23
    Anil Sood, Koji Matsuo, David Gershenson, Surgery for Ovarian Cancer, 2010,

    CrossRef

  24. 24
    Margot M. Veerman, Anneke A. M. van der Wurff, Marije van de Water, Roy F. P. M. Kruitwagen, Harrie W. H. Feijen, Maria Caroline Vos, Clinical Value of Morphometric and DNA Flow Cytometric Variables as Independent Predictors of Survival in Epithelial Ovarian Carcinoma: A 5-year Follow-up Study, International Journal of Gynecological Pathology, 2009, 28, 5, 432

    CrossRef

  25. 25
    U. Ayazpoor, Drittes Gynäkologische-Onkologie-Update-Seminar, Der Gynäkologe, 2009, 42, 7, 542

    CrossRef

  26. 26
    U. Ayazpoor, Ein Fortbildungsformat etabliert sich, Der Onkologe, 2009, 15, 7, 702

    CrossRef

  27. 27
    Hugo Arias-Pulido, Harriet O. Smith, Nancy E. Joste, Therese Bocklage, Clifford R. Qualls, Allison Chavez, Eric R. Prossnitz, Claire F. Verschraegen, Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors, Gynecologic Oncology, 2009, 114, 3, 480

    CrossRef

  28. 28
    Tzu-I Wu, Chyi-Long Lee, Meng-Yu Wu, Swei Hsueh, Kuan-Gen Huang, Chi-Ju Yeh, Chyong-Huey Lai, Prognostic factors predicting recurrence in borderline ovarian tumors, Gynecologic Oncology, 2009, 114, 2, 237

    CrossRef

  29. 29
    Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, Andy Ryan, Matthew Burnell, Aarti Sharma, Sara Lewis, Susan Davies, Susan Philpott, Alberto Lopes, Keith Godfrey, David Oram, Jonathan Herod, Karin Williamson, Mourad W Seif, Ian Scott, Tim Mould, Robert Woolas, John Murdoch, Stephen Dobbs, Nazar N Amso, Simon Leeson, Derek Cruickshank, Alistair Mcguire, Stuart Campbell, Lesley Fallowfield, Naveena Singh, Anne Dawnay, Steven J Skates, Mahesh Parmar, Ian Jacobs, Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), The Lancet Oncology, 2009, 10, 4, 327

    CrossRef

  30. 30
    Marjolijn B. Verbruggen, Paul J. van Diest, Jan P. Baak, Mark A. M. Broeckaert, Peter Kenemans, René H. M. Verheijen, The Prognostic and Clinical Value of Morphometry and DNA Cytometry in Borderline Ovarian Tumors: A Prospective Study, International Journal of Gynecological Pathology, 2009, 28, 1, 35

    CrossRef

  31. 31
    M. ÅKESON, B.-M. ZETTERQVIST, K. DAHLLÖF, A.-M. JAKOBSEN, M. BRÄNNSTRÖM, G. HORVATH, Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period, International Journal of Gynecological Cancer, 2008, 18, 3
  32. 32
    Fatemeh GHAEMMAGHAMI, Tahereh ASHRAF-GANJOOIE, Giti IRAVANLOO, Borderline ovarian tumors, Asia-Pacific Journal of Clinical Oncology, 2007, 3, 1
  33. 33
    Mark I. Hunter, Argyios Ziogas, Francisca Flores, Wendy R. Brewster, Epithelial Ovarian Cancer and Low Malignant Potential (LMP) Tumors Associated With a Lower Incidence of Second Primary Breast Cancer, American Journal of Clinical Oncology, 2007, 30, 1, 1

    CrossRef

  34. 34
    Christer Borgfeldt, Constantin Iosif, Anna Måsbäck, Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer, European Journal of Obstetrics & Gynecology and Reproductive Biology, 2007, 134, 1, 110

    CrossRef

  35. 35
    Andreas OBERMAIR, Sonja HIEBL, Laparoscopy in the treatment of ovarian tumours of low malignant potential, Australian and New Zealand Journal of Obstetrics and Gynaecology, 2007, 47, 6
  36. 36
    Liz Y. Han, Robert L. Coleman, Ovarian Cancer Staging, Operative Techniques in General Surgery, 2007, 9, 2, 53

    CrossRef

  37. 37
    V A Heinzelmann-Schwarz, M Gardiner-Garden, S M Henshall, J P Scurry, R A Scolyer, A N Smith, A Bali, P Vanden Bergh, S Baron-Hay, C Scott, D Fink, N F Hacker, R L Sutherland, P M O'Brien, A distinct molecular profile associated with mucinous epithelial ovarian cancer, British Journal of Cancer, 2006, 94, 6, 904

    CrossRef

  38. 38
    D. O. Bauerschlag, I. Meinhold, C. Schem, C. Mundhenke, W. Jonat, N. Maass, Borderline-Tumor des Ovars, Der Gynäkologe, 2006, 39, 6, 438

    CrossRef

  39. 39
    Fumitaka Kikkawa, Akihiro Nawa, Hiroaki Kajiyama, Kiyosumi Shibata, Kazuhiko Ino, Seiji Nomura, Clinical characteristics and prognosis of mucinous tumors of the ovary, Gynecologic Oncology, 2006, 103, 1, 171

    CrossRef

  40. 40
    Y Yokoyama, T Moriya, T Takano, T Shoji, O Takahashi, K Nakahara, H Yamada, N Yaegashi, K Okamura, T Izutsu, T Sugiyama, T Tanaka, H Kurachi, A Sato, T Tase, H Mizunuma, Clinical outcome and risk factors for recurrence in borderline ovarian tumours, British Journal of Cancer, 2006,

    CrossRef

  41. 41
    S Biade, M Marinucci, J Schick, D Roberts, G Workman, E H Sage, P J O'Dwyer, V A LiVolsi, S W Johnson, Gene expression profiling of human ovarian tumours, British Journal of Cancer, 2006, 95, 8, 1092

    CrossRef

  42. 42
    Lovisa Österberg, Margaretha Åkeson, Kristina Levan, Karolina Partheen, Britt-Marie Zetterqvist, Mats Brännström, György Horvath, Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas, Cancer Genetics and Cytogenetics, 2006, 167, 2, 103

    CrossRef

  43. 43
    Jesse K. McKenney, Bonnie L. Balzer, Teri A. Longacre, Lymph Node Involvement in Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors), The American Journal of Surgical Pathology, 2006, 30, 5, 614

    CrossRef

  44. 44
    Manabu Fukumoto, Kentaro Nakayama, Ovarian epithelial tumors of low malignant potential: Are they precursors of ovarian carcinoma?, Pathology International, 2006, 56, 5
  45. 45
    Michael A. Bidus, Joel C. Webb, Jeffrey D. Seidman, G. Scott Rose, Charles R. Boice, John C. Elkas, Sustained response to bevacizumab in refractory well-differentiated ovarian neoplasms, Gynecologic Oncology, 2006, 102, 1, 5

    CrossRef

  46. 46
    Isabelle Cadron, Frederic Amant, Toon Van Gorp, Patrick Neven, Karin Leunen, Ignace Vergote, The management of borderline tumours of the ovary, Current Opinion in Oncology, 2006, 18, 5, 488

    CrossRef

  47. 47
    Y. Lenglet, H. Roman, B. Rabishong, N. Bourdel, M. Bonnin, F. Bolandard, P. Duband, J.-L. Pouly, G. Mage, M. Canis, Traitement cœlioscopique des kystes de l'ovaire au cours de la grossesse, Gynécologie Obstétrique & Fertilité, 2006, 34, 2, 101

    CrossRef

  48. 48
    Claire L. Templeman, Mary E. Fallat, Pediatric Surgery, 2006,

    CrossRef

  49. 49
    Rong Yu Zang, Wen Tao Yang, Da Ren Shi, Yan Xing, Shu Mo Cai, Recurrent ovarian carcinoma of low malignant potential: The role of secondary surgical cytoreduction and the prognosis in Chinese patients, Journal of Surgical Oncology, 2005, 91, 1
  50. 50
    Geza Acs, Serous and Mucinous Borderline (Low Malignant Potential) Tumors of the Ovary, Pathology Patterns Reviews, 2005, 123, 1, S1

    CrossRef

  51. 51
    R J Kurman, J D Seidman, I-M Shih, Serous borderline tumours of the ovary, Histopathology, 2005, 47, 3
  52. 52
    Mark E Sherman, Jules Berman, Michael J Birrer, Kathleen R Cho, Lora Hedrick Ellenson, Fred Gorstein, Jeffrey D Seidman, Current challenges and opportunities for research on borderline ovarian tumors, Human Pathology, 2004, 35, 8, 961

    CrossRef

  53. 53
    Virginia A LiVolsi, Zubair W Baloch, Follicular Neoplasms of the Thyroid, Advances in Anatomic Pathology, 2004, 11, 6, 279

    CrossRef

  54. 54
    Hot Papers in the Literature, Journal of Women's Health, 2004, 13, 6, 745

    CrossRef

  55. 55
    Ramez N. Eskander, Teresa P. Díaz-Montes, Russell Vang, Deborah K. Armstrong, Robert E. Bristow, Borderline Tumors and Other Rare Epithelial Tumors of the Ovary,